The rise of Viagra initially fueled a boom for the drug industry, but recent changes present a murky outlook for shareholders. Off-patent competitors are eroding profits, and ongoing patent challenges add further risk https://jeandjze542090.blog-ezine.com/41735601/sildenafil-and-pharma-a-precarious-bet